Odontoprev S.A
Odontoprev S.A. provides private dental care plans in Brazil. The company operates through Corporate, Small and Medium-Sized Enterprise (SME), Individual, and Other segments. The company manages and sells dental care plans to corporations and/or individuals. It is also involved in commercial advisory, consulting, and business management services; develops and licenses software programs; wholesale… Read more
Odontoprev S.A (ODPV3) - Net Assets
Latest net assets as of September 2025: R$1.29 Billion BRL
Based on the latest financial reports, Odontoprev S.A (ODPV3) has net assets worth R$1.29 Billion BRL as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (R$2.25 Billion) and total liabilities (R$958.26 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | R$1.29 Billion |
| % of Total Assets | 57.39% |
| Annual Growth Rate | 23.66% |
| 5-Year Change | 1.79% |
| 10-Year Change | 87.86% |
| Growth Volatility | 383.58 |
Odontoprev S.A - Net Assets Trend (2003–2024)
This chart illustrates how Odontoprev S.A's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Odontoprev S.A (2003–2024)
The table below shows the annual net assets of Odontoprev S.A from 2003 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | R$1.23 Billion | -11.49% |
| 2023-12-31 | R$1.39 Billion | +17.05% |
| 2022-12-31 | R$1.19 Billion | +5.73% |
| 2021-12-31 | R$1.12 Billion | -7.07% |
| 2020-12-31 | R$1.21 Billion | +8.07% |
| 2019-12-31 | R$1.12 Billion | +8.22% |
| 2018-12-31 | R$1.03 Billion | +11.34% |
| 2017-12-31 | R$926.61 Million | +32.81% |
| 2016-12-31 | R$697.71 Million | +6.72% |
| 2015-12-31 | R$653.79 Million | +1.48% |
| 2014-12-31 | R$644.25 Million | -7.67% |
| 2013-12-31 | R$697.80 Million | -5.51% |
| 2012-12-31 | R$738.52 Million | -3.34% |
| 2011-12-31 | R$764.04 Million | +6.20% |
| 2010-12-31 | R$719.46 Million | -17.33% |
| 2009-12-31 | R$870.27 Million | +255.32% |
| 2008-12-31 | R$244.92 Million | +7.66% |
| 2007-12-31 | R$227.50 Million | +15.94% |
| 2006-12-31 | R$196.22 Million | +1797.48% |
| 2005-12-31 | R$10.34 Million | -51.41% |
| 2004-12-31 | R$21.28 Million | +49.81% |
| 2003-12-31 | R$14.21 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Odontoprev S.A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 10127.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | R$492.29 Million | 40.10% |
| Common Stock | R$851.02 Million | 69.31% |
| Other Comprehensive Income | R$-43.97 Million | -3.58% |
| Total Equity | R$1.23 Billion | 100.00% |
Odontoprev S.A Competitors by Market Cap
The table below lists competitors of Odontoprev S.A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Xiamen Port Development Co Ltd
SHE:000905
|
$548.17 Million |
|
Raffles Medical Group Ltd
F:02M1
|
$548.22 Million |
|
Universal Health Realty Income Trust
NYSE:UHT
|
$548.70 Million |
|
STAAR Surgical Company
NASDAQ:STAA
|
$548.73 Million |
|
Three Squirrels
SHE:300783
|
$548.09 Million |
|
Beijing Tianyishangjia New Material Corp Ltd
SHG:688033
|
$547.67 Million |
|
Europower Enerji ve Otomasyon Teknolojileri Sanayi Ticaret A.S.
IS:EUPWR
|
$547.62 Million |
|
Yulon Finance Corp
TW:9941
|
$547.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Odontoprev S.A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,386,994,000 to 1,227,769,000, a change of -159,225,000 (-11.5%).
- Net income of 539,244,000 contributed positively to equity growth.
- Dividend payments of 542,758,000 reduced retained earnings.
- Share repurchases of 69,153,000 reduced equity.
- Other comprehensive income decreased equity by 18,264,000.
- Other factors decreased equity by 68,294,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | R$539.24 Million | +43.92% |
| Dividends Paid | R$542.76 Million | -44.21% |
| Share Repurchases | R$69.15 Million | -5.63% |
| Other Comprehensive Income | R$-18.26 Million | -1.49% |
| Other Changes | R$-68.29 Million | -5.56% |
| Total Change | R$- | -11.48% |
Book Value vs Market Value Analysis
This analysis compares Odontoprev S.A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.88x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 302.13x to 5.88x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | R$0.04 | R$13.20 | x |
| 2004-12-31 | R$0.07 | R$13.20 | x |
| 2005-12-31 | R$0.03 | R$13.20 | x |
| 2006-12-31 | R$0.58 | R$13.20 | x |
| 2007-12-31 | R$0.68 | R$13.20 | x |
| 2008-12-31 | R$0.74 | R$13.20 | x |
| 2009-12-31 | R$2.54 | R$13.20 | x |
| 2010-12-31 | R$1.21 | R$13.20 | x |
| 2011-12-31 | R$1.30 | R$13.20 | x |
| 2012-12-31 | R$1.19 | R$13.20 | x |
| 2013-12-31 | R$1.18 | R$13.20 | x |
| 2014-12-31 | R$1.09 | R$13.20 | x |
| 2015-12-31 | R$1.11 | R$13.20 | x |
| 2016-12-31 | R$1.17 | R$13.20 | x |
| 2017-12-31 | R$1.56 | R$13.20 | x |
| 2018-12-31 | R$1.75 | R$13.20 | x |
| 2019-12-31 | R$1.90 | R$13.20 | x |
| 2020-12-31 | R$2.06 | R$13.20 | x |
| 2021-12-31 | R$1.92 | R$13.20 | x |
| 2022-12-31 | R$2.14 | R$13.20 | x |
| 2023-12-31 | R$2.51 | R$13.20 | x |
| 2024-12-31 | R$2.25 | R$13.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Odontoprev S.A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 43.92%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 23.64%
- • Asset Turnover: 1.07x
- • Equity Multiplier: 1.73x
- Recent ROE (43.92%) is above the historical average (36.90%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 45.56% | 6.86% | 2.57x | 2.58x | R$5.05 Million |
| 2004 | 56.49% | 4.99% | 4.88x | 2.32x | R$9.89 Million |
| 2005 | 171.70% | 12.01% | 3.07x | 4.66x | R$16.72 Million |
| 2006 | 8.62% | 8.96% | 0.77x | 1.24x | R$-2.71 Million |
| 2007 | 20.91% | 18.36% | 0.85x | 1.35x | R$24.83 Million |
| 2008 | 22.57% | 17.33% | 0.94x | 1.39x | R$30.71 Million |
| 2009 | 9.65% | 21.93% | 0.31x | 1.40x | R$-3.07 Million |
| 2010 | 30.49% | 31.39% | 0.76x | 1.27x | R$147.17 Million |
| 2011 | 19.05% | 17.40% | 0.81x | 1.35x | R$69.05 Million |
| 2012 | 20.79% | 15.23% | 0.92x | 1.48x | R$75.56 Million |
| 2013 | 27.04% | 17.59% | 1.00x | 1.54x | R$118.52 Million |
| 2014 | 30.33% | 16.84% | 1.05x | 1.72x | R$130.51 Million |
| 2015 | 33.91% | 17.68% | 1.05x | 1.83x | R$155.79 Million |
| 2016 | 31.14% | 15.82% | 1.01x | 1.95x | R$146.63 Million |
| 2017 | 54.47% | 34.99% | 1.03x | 1.51x | R$410.59 Million |
| 2018 | 27.72% | 17.89% | 0.97x | 1.60x | R$182.05 Million |
| 2019 | 25.62% | 15.74% | 1.02x | 1.59x | R$173.63 Million |
| 2020 | 30.04% | 20.46% | 0.92x | 1.60x | R$240.90 Million |
| 2021 | 34.09% | 20.60% | 0.95x | 1.73x | R$268.78 Million |
| 2022 | 30.90% | 19.73% | 0.92x | 1.71x | R$247.44 Million |
| 2023 | 36.87% | 24.14% | 0.98x | 1.56x | R$372.69 Million |
| 2024 | 43.92% | 23.64% | 1.07x | 1.73x | R$416.47 Million |
Industry Comparison
This section compares Odontoprev S.A's net assets metrics with peer companies in the Healthcare Plans industry.
Industry Context
- Industry: Healthcare Plans
- Average net assets among peers: $1,301,570,000
- Average return on equity (ROE) among peers: 0.51%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Odontoprev S.A (ODPV3) | R$1.29 Billion | 45.56% | 0.74x | $548.11 Million |
| Qualicorp Consultoria e Corretora de Seguros S.A (QUAL3) | $1.30 Billion | 0.51% | 2.35x | $43.69 Million |